When that damn iceberg hits the titanic of "the way things are usually done" - the ship will go down a lot faster for there to be any survivors (in Big Pharma).
That will be the dawn of a new day in CNS therapeutics development.
That’s been the plan all along because he knows we’ve got this in the bag. So don’t attract too much attention
I think you raise/make some excellent points. I would add that this path is ultimately not sustainable, eventually he must deliver. The sooner the better for even the most loyal holders.